What is the current stock price of CannLabs, Inc. (CANL)?

As of the latest market data, CannLabs, Inc. (CANL) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does CannLabs, Inc. (CANL) pay a dividend?

Based on current data, CannLabs, Inc. does not have a confirmed active dividend policy.

What is the market cap of CannLabs, Inc.?

The current market capitalization of CannLabs, Inc. (CANL) is approximately unavailable.

CANL

CannLabs, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.01

CANL NEWS

defenseworld.net

Jan 28

Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Cannlabs (OTCMKTS:CANL)

Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings. Profitability This table compares Cannlabs and NeuroOne Medical

Company Profile

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

IPO Date

2014-06-13

Beta

5.59

Websitewww.cannlabs.net↗